Curacle Co., Ltd. engages in the business of research and experimental development in medical sciences and pharmacy. It develops drugs for various intractable diseases caused by vascular endothelial dysfunction and aging. The company was founded by Yeong-Geun Kwon on May 12, 2016 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company